))
Insulet integrates Abbott FreeStyle Libre 2 Plus, Omnipod 5
Manage episode 399897276 series 3481361
Contenuto fornito da Fast Five by MassDevice. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Fast Five by MassDevice o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 8, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. ShiraTronics completed its implantable migraine therapy pilot enrollment and set up its U.S. clinical study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and what some of the data has shown so far. TAVR and Critical Care drove Edwards to its fourth-quarter sales beat. Hear more about the overall financial performance and how some of the individual segments performed. Nature Journal is raising questions about Neuralink's BCI study. Whooley explains some of the concerns and why they are important. Medtronic is touting the cost-effectiveness of Linq insertable cardiac monitors. The Fast Five hosts go over what the technology does and what data supported that claim. Insulet has integrated Abbott FreeStyle Libre 2 Plus into the Omnipod 5 technology in Europe. Learn more about the approval and why it's important for Abbott.
…
continue reading
161 episodi
Condividi
